Research graph
References from Abrupt Onset of Crescentic IgA Nephropathy Superimposed on Glycogen Storage Disease Type Ia: A 15-Year Longitudinal Pediatric Case Report. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
1993 · External reference
Unresolved reference
2022 · External reference
Unresolved reference
2016 · External reference
Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy
10.1007/s10545-017-0054-2 · 2017 · External reference
Glycogen storage disease type I: Genetic etiology, clinical manifestations, and conventional and gene therapies
10.1002/pdi3.3 · 2023 · External reference
Nocturnal gastric drip feeding in glucose-6-phosphatase deficient children
10.1203/00006450-197904000-00003 · 1979 · External reference
The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate
10.1203/00006450-198409000-00015 · 1984 · External reference
Renal involvement in type I glycogen storage disease. Report of one case
10.1093/ndt/9.8.1179 · 1994 · External reference
Renal lesion of type Ia glycogen storage disease: the glomerular size and renal localization of apolipoprotein
1995 · External reference
Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective study
10.1111/j.1365-2265.2005.02292.x · 2005 · External reference
Kidney and Metabolic Phenotypes in Glycogen Storage Disease Type-I Patients
10.3389/fped.2020.00591 · 2020 · External reference
Renal disease in type I glycogen storage disease
10.1056/nejm198801073180102 · 1988 · External reference
Renal histology in two adult patients with type I glycogen storage disease
1993 · External reference
Renal glomerular and tubular abnormalities in glycogen storage disease type I
1988 · External reference
Renal involvement in type I glycogen storage disease
1995 · External reference
Transforming growth factor-beta in renal disease with glycogen storage disease I
10.1007/s00467-004-1456-6 · 2004 · External reference
Renal disease in an adult patient with type I glycogen storage disease
10.3109/08860229509037646 · 1995 · External reference
Progressive development of renal cysts in glycogen storage disease type I
10.1093/hmg/ddw224 · 2016 · External reference
Glomerular hyperfiltration: a marker of early renal damage in pre-diabetes and pre-hypertension
10.1093/ndt/gfs037 · 2012 · External reference
Renal endoplasmic reticulum stress is coupled to impaired autophagy in a mouse model of GSD Ia
10.1016/j.ymgme.2017.08.013 · 2017 · External reference
Hyperfiltration and renal disease in glycogen storage disease, type I
10.1038/ki.1989.133 · 1989 · External reference
Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition
10.2215/cjn.00050109 · 2009 · External reference
IgA nephropathy
10.1038/s41572-023-00476-9 · 2023 · External reference
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1
2008 · External reference
Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a
10.1126/science.8211187 · 1993 · External reference
Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)
10.1038/srep44408 · 2017 · External reference
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
10.1038/ki.2009.499 · 2010 · External reference
Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy
10.1093/ndt/gfh536 · 2004 · External reference
Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome
10.1007/s00467-003-1370-3 · 2004 · External reference
Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome
10.1093/ndt/12.11.2433 · 1997 · External reference
Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy
10.1159/000337175 · 2012 · External reference
Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy
10.3389/fphar.2023.1189608 · 2023 · External reference
Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)
10.1111/j.1399-0012.1996.tb00651.x · 1996 · External reference
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A
10.1038/nm.1857 · 2008 · External reference
